MedTrace Logo

Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

NCT04728113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2025-09-08

No results posted yet for this study

Summary

The study main objective is to assess whether the early introduction of supportive care demonstrates a benefit on patients' psychological care needs at 6 months (M6), versus oncological standard of care in patients with metastatic UM.

Supportive care in patients with metastatic Uveal Melanoma (UM)

Conditions

Interventions

OTHER

Supportive care visit with questionnaires

5 Questionnaires (SCNS, QLQ-C30, HADS, PTPQ, GSE) will be filled by the patient with introduction of supportive care visit

OTHER

Oncological standard visit

Oncological standard visit

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • PIPERNO NEUMAN Sophie, MD · Institut Curie

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-16
Primary Completion
2025-01-22
Completion
2025-01-22

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04728113 on ClinicalTrials.gov